Europe to personalise prevention of second heart attacks
Cardiovascular disease (CVD) is the top cause of death in Europe and worldwide, accounting for 47% of deaths in women and 39% of deaths in men.1 CVD costs the EU more than €210 billion a year,2 a sum expected to escalate with an ageing population and the cost of novel therapies.
Eating meat, including chicken, linked to heart disease risk in study
Eating meat has been linked to heart disease in the latest study to suggest the food could pose some risk to our health.
Periodontitis increases the risk of suffering from future atherosclerotic cardiovascular disease
It was already known, but so far there was no rigorous and exhaustive report that corroborated the link between periodontitis and the future risk of developing atherosclerotic cardiovascular disease. Now two of the international reference entities in the field of periodontal and cardiovascular health, the European Federation of Periodontics (VET) and the World Heart Federation (WHF), publish a consensus powerful that leaves no room for doubt.
PARTNER 2A Intermediate-Risk TAVR Five-Year Results Hit Print
Late outcomes of transcatheter aortic valve replacement (TAVR) in the PARTNER 2A trial are now enshrined in the peer-reviewed literature.
New report reveals the role of physical activity in preventing and treating cardiovascular diseases
The European Heart Network, in collaboration with the WHO European Office for the Prevention and Control of Noncommunicable Diseases, has published an important report on physical activity policies for cardiovascular health. Each year, cardiovascular diseases cause 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. Physical inactivity increases the risk of cardiovascular diseases by more than 20%.
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement
Whether the direct factor Xa inhibitor rivaroxaban can prevent thromboembolic events after transcatheter aortic-valve replacement (TAVR) is unclear.
Ticagrelor Sans Aspirin Trial Answers Some Questions About DAPT
Hi. My name is Robert Byrne. I'm an interventional cardiologist at the German Heart Center in Munich and am here at TCT 2019 in San Francisco, where we've seen some interesting results from the TWILIGHT study. I would like to discuss some of the implications of this study for clinical practice.
From Naysayer to Convert: Cardiologists Should Prescribe SGLT2 Inhibitors
Сardiologists have largely resisted calls to get more involved in diabetes. The comments on the Medscape article "Cardiologists Must Get Up to Speed on Treating Diabetes" echoed the sentiments of many regarding sodium-glucose contransporter-2 (SGLT2) prescribing.
MITRA-FR at 2 Years: MitraClip Still No Better Than Med Therapy Patrice Wendling
PARIS — An additional year of follow-up in the MITRA-FR trial confirm no added benefit of percutaneous repair of functional mitral regurgitation (MR) with the MitraClip (Abbott) compared with optimal medical therapy alone.
Daily Aspirin May Lower Risk for Fatty Liver Progression
Taking daily aspirin may prevent progression of nonalcoholic fatty liver disease (NAFLD) to liver fibrosis and nonalcoholic steatopepatitis (NASH), according to a study published online May 8 in Clinical Gastroenterology and Hepatology.
In memory of Umida Kabirovna Kamilova
November 21, 2023. Passed away at the age of 61. Professor Umida Kabirovna Kamilova, Doctor of Medical Sciences. She devoted her life and work to medicine.
ACC/AHA Issue Updated Atrial Fibrillation Guideline
The American College of Cardiology (ACC), the American Heart Association (AHA), the American College of Chest Physicians (ACCP), and the Heart Rhythm Society (HRS) have issued an updated guideline for preventing and optimally managing atrial fibrillation (AF).
ESC 2019: Wrap up in Russian - Live and interactive programme
In collaboration with the Russian Society of Cardiology, this programme is designed to present a selection of scientific highlights from ESC Congress and discuss clinical practice implications with experts.
ESC Congress 2019 together with World Congress of Cardiology
ESC Congress 2019
together with World Congress of Cardiology
Saturday 31 August - Wednesday 4 September 2019
Paris - France
Announcement of the European Congress of Cardiology
From August 31 to September 4, 2019, he Congress of the European Society of Cardiology in conjunction with the World Congress of Cardiology - will be held in Paris (France).
Trial Evaluating Sacubitril/Valsartan for HFpEF Misses Primary End Point
Full detailed data from PARAGON-HF will be presented at the ESC Congress 2019 in September.
Novartis announced topline results from the phase 3 PARAGON-HF study evaluating the safety and efficacy of sacubitril/valsartan (Entresto) in heart failure patients with preserved ejection fraction (HFpEF).
ESC Congress 2019 together with World Congress of Cardiology
Full detailed data from PARAGON-HF will be presented at the ESC Congress 2019 in September.
Novartis announced topline results from the phase 3 PARAGON-HF study evaluating the safety and efficacy of sacubitril/valsartan (Entresto) in heart failure patients with preserved ejection fraction (HFpEF).
Certain Social, Behavioral Factors Associated With Diabetes and Hypertension Onset
Education and exercise may determine early start of diabetes and hypertension.
Select behavioral and social risk factors were correlated with early onset of hypertension and diabetes, a prospective cohort study found.
At 3.5 years of follow-up, among the patients without diabetes at baseline, 4% developed diabetes, while 6.4% of the cohort without baseline hypertension developed hypertension, reported Matthew Pantell, MD, MS, of the University of California, San Francisco, and colleagues.
THE FEATS OF DOCTORS DURING THE GREAT PATRIOTIC WAR (WORLD WAR II)
During the war years, more than 700 thousand doctors and medical professionals worked at the front. At the end of the war, 12.5% of all these people were killed, and this figure seriously exceeds the losses in each individual military unit. But despite the danger, they never gave up, and in the most extreme situations only the iron will helped them to pull hundreds of people from the other world, and again to return to the battlefields. They achieved amazing results, and during the entire war, thanks to medical workers, about 72 percent of wounded soldiers and 90 percent of sick people, that is, approximately 17 million people, returned to the system.
The Congress for Cardiology and Internal medicine of Asian and CIS countries
On April 26 - 27, 2019, the Congress for Cardiology and Internal medicine of Asian and CIS countries was held in Dushanbe (Tajikistan). The congress was organized by the Ministry of Health and Social Protection of Tajikistan and the Cardioprogress Foundation. In the opening ceremony, the Minister, Professor Olimzoda Nasim Khoja addressed the participants with greetings.